Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification.
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification. Res Sq. 2025 Aug 05.
PMID: 40799764
Triadic Primary Care Encounters Managing Medications Among Individuals With Mild Cognitive Impairment and Dementia: Patient, Caregiver, and Clinician Perspectives.
Triadic Primary Care Encounters Managing Medications Among Individuals With Mild Cognitive Impairment and Dementia: Patient, Caregiver, and Clinician Perspectives. Gerontologist. 2025 Jun 12; 65(7).
PMID: 40177942
Democratizing dementia research through global online conferences.
Democratizing dementia research through global online conferences. Nat Neurosci. 2025 Jun; 28(6):1109-1112.
PMID: 40325214
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia.
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. Alzheimers Dement. 2025 Apr; 21(4):e14608.
PMID: 40277074
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts. Ann Neurol. 2025 Aug; 98(2):236-248.
PMID: 40091774
The causal association between resting state intrinsic functional networks and neurodegeneration.
The causal association between resting state intrinsic functional networks and neurodegeneration. Brain Commun. 2025; 7(2):fcaf098.
PMID: 40103583
Efficacy of Communication Bridge-2 for primary progressive aphasia: A randomized controlled trial of communication intervention.
Efficacy of Communication Bridge-2 for primary progressive aphasia: A randomized controlled trial of communication intervention. Alzheimers Dement. 2025 Mar; 21(3):e70088.
PMID: 40145390
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort.
Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort. Alzheimers Dement. 2025 Mar; 21(3):e70075.
PMID: 40145384
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts.
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts. Alzheimers Dement. 2025 Feb; 21(2):e14489.
PMID: 39968692
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials. J Prev Alzheimers Dis. 2025 Apr; 12(4):100075.
PMID: 39956674